Oracle enterprise database and application server administration support

Active Indefinite Delivery Contract Awarded Last action

Contract number
75F40122D00025
Awardee
Awarding agency
Task orders
6 $35,916,347 obligated

Award facts

Opportunity
Combined order value
  • $35,916,347 Current, with exercised options
  • $47,743,719 Potential, with all options
Last date to order 82% complete
IDV ceiling 38% used
$95,000,000.00
Maximum order
$95,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
Competitive 8(a)
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The Food and Drug Administration awarded a single-award indefinite delivery contract to Tuvli LLC to provide Oracle enterprise database and application server administration support services. The contract has a potential value of $95 million over a five-year period of performance from September 2022 through September 2027. Four firm fixed price delivery orders were awarded against the contract to support FDA's Digital Acceleration Service, Center for Drug Evaluation and Research, Center for Food Safety and Applied Nutrition, and Office of Information Management and Technology Oracle environments. Delivery order values range from $4.3 million to $16 million, with periods of performance through October 2027 and places of performance in Herndon, Virginia and Rockville, Maryland.

The originating solicitation sought proposals for the indefinite delivery contract to provide Oracle database and application server administration services across multiple task orders supporting over 250 Oracle databases across 18 servers in four environments. Proposals were evaluated based on technical approach, management plan, and pricing, with non-price factors considered more important than cost. The requirement was set aside for 8(a) small businesses and resulted in the single award to Tuvli LLC. Services will support FDA's critical information technology infrastructure and systems that manage regulated product and compliance information.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00002 -$1,000
Other Administrative Action P00001 $0
Original award $1,000

Quick answers

Who was awarded contract 75F40122D00025?

75F40122D00025 was awarded to Tuvli LLC by Food and Drug Administration (Department of Health and Human Services) on September 22, 2022.

How much is contract 75F40122D00025 worth?

Orders under 75F40122D00025 have obligated $35,916,347. Their combined potential value, with all options, is $47,743,719. 75F40122D00025's own ceiling is $95,000,000. A single order can be worth up to $95,000,000.

How many orders have been placed under contract 75F40122D00025?

6 orders have been placed under 75F40122D00025, the latest on November 6, 2024.

Who can order from contract 75F40122D00025?

75F40122D00025 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75F40122D00025 competed?

The extent of competition for 75F40122D00025 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Competitive 8(a).

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV